Michael J. Ostacher, MD, MPH

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California; The University of Chicago, Chicago, Illinois (Isaac, Radovan); Department of Psychiatry, Veterans Affairs Palo Alto Health Care System, Palo Alto, California

  • 16Articles
  • 54KReads
  • 2005–2026Active
  • 49Collaborators
  • 178Citations

About

Michael J. Ostacher, MD, MPH, is affiliated with the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine, The University of Chicago, and the Veterans Affairs Palo Alto Health Care System. With publications spanning from 2005 to 2026, Ostacher has contributed extensively to topics including bipolar disorder, major depressive disorder, addiction, posttraumatic stress disorder, psychopharmacology, and veterans' mental health. His work encompasses clinical practice guidelines, psychiatric drug development, medication adherence, and patient care strategies. Frequent collaborators include Andrew A. Nierenberg, Gary S. Sachs, and Roy H. Perlis.

Publications

JCP
Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024
Original Research

Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024

January 12, 2026

Innovation in psychiatric drug development in the past 13 years was limited, with most new drugs representing incremental advances rather than groundbreaking innovations.
, , , et al
JCP
Synopsis of the VA/DOD Clinical Practice Guideline for Management of Bipolar Disorder
Consensus Statement

Synopsis of the VA/DOD Clinical Practice Guideline for Management of Bipolar Disorder

January 13, 2025

This synopsis focuses on clinically relevant recommendations related to identification and management of bipolar disorder, including the acute and maintenance phases of illness.
, , , et al
JCP
What Does a Systematic Review of Cannabis and PTSD Tell Us? That We Need to Learn More
Commentary

What Does a Systematic Review of Cannabis and PTSD Tell Us? That We Need to Learn More

February 14, 2024

Dr Ostacher discusses a review by Rodas et al and points to a need for clear answers on how best to advise patients with PTSD and other psychiatric illness...
JCP
Commentary

Follow-Up Appointments for Patients After Discharge

September 15, 2020

This commentary discusses the article by Smith et al on the benefits of scheduling post-discharge outpatient mental health appointments for patients released from the hospital and notes factors that...
JCP
ASCP Corner

Depression with Mixed Features in MDD

January 30, 2018

Read an article describing depression with mixed features in Major Depressive Disorder (MDD) and the treatment of patients who meet the criteria.
,
JCP
Consensus Statement

Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Bipolar Disorder: A Novel, Practical, Patient-Centered Guide for Clinicians

July 27, 2016

, ,
JCP
Educational Activity

Controversies in the Psychopharmacology of Bipolar Disorder

November 24, 2014

, ,
JCP
Commentary

When Positive Isn' t Positive: The Hopes and Disappointments of Clinical Trials

October 28, 2014

JCP
Original Research

Clinical Features Associated With Poor Pharmacologic Adherence in Bipolar Disorder: Results From the STEP-BD Study

March 15, 2010

, , , et al
JCP
Original Research

Benzodiazepine Use and Risk of Recurrence in Bipolar Disorder: A STEP-BD Report

February 15, 2010

, , , et al
JCP
Letter to the Editor

Reply to Is Smoking Associated With Suicide in Bipolar Patients?

September 17, 2007

, ,
JCP
Original Research

The Relationship Between Smoking and Suicidal Behavior, Comorbidity, and Course of Illness in Bipolar Disorder

December 15, 2006

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe